[go: up one dir, main page]

GB201416773D0 - Novel Methods For Including An Imune Response - Google Patents

Novel Methods For Including An Imune Response

Info

Publication number
GB201416773D0
GB201416773D0 GBGB1416773.8A GB201416773A GB201416773D0 GB 201416773 D0 GB201416773 D0 GB 201416773D0 GB 201416773 A GB201416773 A GB 201416773A GB 201416773 D0 GB201416773 D0 GB 201416773D0
Authority
GB
United Kingdom
Prior art keywords
novel methods
imune
imune response
response
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1416773.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB1416773.8A priority Critical patent/GB201416773D0/en
Publication of GB201416773D0 publication Critical patent/GB201416773D0/en
Priority to PCT/EP2015/071562 priority patent/WO2016046113A1/en
Priority to BE2015/5585A priority patent/BE1022950B1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB1416773.8A 2014-09-23 2014-09-23 Novel Methods For Including An Imune Response Ceased GB201416773D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1416773.8A GB201416773D0 (en) 2014-09-23 2014-09-23 Novel Methods For Including An Imune Response
PCT/EP2015/071562 WO2016046113A1 (en) 2014-09-23 2015-09-21 Novel methods for inducing an immune response
BE2015/5585A BE1022950B1 (en) 2014-09-23 2015-09-21 METHODS OF INDUCING AN IMMUNE RESPONSE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1416773.8A GB201416773D0 (en) 2014-09-23 2014-09-23 Novel Methods For Including An Imune Response

Publications (1)

Publication Number Publication Date
GB201416773D0 true GB201416773D0 (en) 2014-11-05

Family

ID=51869339

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1416773.8A Ceased GB201416773D0 (en) 2014-09-23 2014-09-23 Novel Methods For Including An Imune Response

Country Status (3)

Country Link
BE (1) BE1022950B1 (en)
GB (1) GB201416773D0 (en)
WO (1) WO2016046113A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3442570A1 (en) 2016-04-12 2019-02-20 Oxford University Innovation Limited Prime target
GB201608821D0 (en) 2016-05-19 2016-07-06 Isis Innovation Vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0420634D0 (en) * 2004-09-16 2004-10-20 Glaxosmithkline Biolog Sa Vaccines
MX2010001752A (en) * 2007-08-13 2010-03-10 Glaxosmithkline Biolog Sa Vaccines.

Also Published As

Publication number Publication date
BE1022950A1 (en) 2016-10-21
BE1022950B1 (en) 2016-10-21
WO2016046113A1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
GB201406151D0 (en) Method
GB201409558D0 (en) Method
SG11201700172WA (en) Method
GB201406155D0 (en) Method
GB201408119D0 (en) Method
GB201410262D0 (en) Novel method
ZA201704602B (en) Dihydroindolizinone derivative
GB201403470D0 (en) Method
GB201410022D0 (en) Method
ZA201605955B (en) Novel methods for inducing an immune response
GB201420832D0 (en) Location method
GB201410101D0 (en) Method
IL248772A0 (en) Cyclohexyl-pyridine derivative
GB201409234D0 (en) Method
GB201409128D0 (en) Method
GB201416773D0 (en) Novel Methods For Including An Imune Response
GB201409101D0 (en) Method
GB201407971D0 (en) Method
GB201401565D0 (en) Novel method
GB201410462D0 (en) Method
GB201409127D0 (en) Method
GB201409067D0 (en) Method
GB201408160D0 (en) Method
GB201407948D0 (en) Method
GB201407815D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)